Novant Health announces new leader in cancer services

WINSTON-SALEM, N.C., Jan. 18, 2017 – Novant Health announces a new system service line cancer leader, Dr. Steven Limentani, effective Jan. 1, 2017. Limentani will lead cancer services across the Novant Health system covering a four-state area including hematology, medical oncology, radiation oncology, surgical oncology, gynecologic oncology and oncology research.

Limentani is certified by the American Board of Internal Medicine in hematology, medical oncology and internal medicine. He is a graduate of Tufts University School of Medicine where he obtained a doctorate in medicine with honors in research.

He did his residency in internal medicine at the New England Deaconess Hospital, a major teaching hospital of Harvard Medical School. He completed his hematology and oncology training at Tufts- New England Medical Center in Boston where he remained on the faculty until moving to North Carolina. Limentani has extensive experience with physician and service line leadership with a particular interest in population health and clinical research trials.

Having practiced in the Charlotte market since 1995 where he was the medical director of clinical trials at the Levine Cancer Institute, Limentani focused on the care of patients with breast cancer. Most recently he served as vice president, cancer services and chief research officer at Mission Health in Asheville, North Carolina.